Centro Pediatrico Albina Patiño
Cochabamba, 591, Bolivia
NCT Number: NCT00683982
Nitazoxanide has proved an cytoprotective effect against rotavirus infection. How it could be clinically important in time of hospitalization and reduction of duration of diarrhea secondary to rotavirus?
Looking for future studies?
Notify Me28 day–24 month
All sexes
Interventional
Not applicable
Cochabamba, 591, Bolivia
Nitazoxanide has demonstrated a cytoprotective effect against rotavirus, reducing duration time of diarrhea in comparison to placebo in previous studies. In the current study, based in those results, we design a randomized single-blind controlled trial, in order to asses the effectiveness of nitazoxanide and probiotics in comparison with a control group
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nitazoxanide 15mg/Kg/day twice day for 3 days
Other names: Noxom; Givotan
Probiotic preparation 1 gram twice a day for 5 days
Other names: Probiotic
Oral hydration solutions as needed
Other names: Rehsal 60, 2.5% Glucosaline
Time frame: Hours
Time frame: hours
Centro Pediatrico Albina de Patino
Other
Nitazoxanide vs Probiotics in the Treatment of Acute Rotavirus Diarrhea in Children: A Randomized Single Blind Controlled Trial in Bolivian Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00981877
Diarrhea, Infections
Cochabamba, Bolivia
View Trial DetailsNCT01467037
Diarrhea, Digestive System Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT02875249
Diarrhea, Pathological Conditions, Signs and Symptoms
Nantes, France
View Trial DetailsNCT06268717
Abdominal Pain, Alpha-Gal Syndrome
Chapel Hill, North Carolina, United States
View Trial Details